Next, we tested whether the expression of TMEM123 responded to T-cell receptor (TCR) activation via anti-CD3/CD28 T cell activation and to tumor microenvironmental stimuli known to affect fates and intrinsic pathways of T lymphocytes, relevant for trafficking, differentiation and function. This evidence concerns the gene CD28 and neoplasm.